SCHEMBL12971559

SCHEMBL12971559

O=C(O)Nc1ccc(Oc2cc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)ccc2C(=O)NS(=O)(=O)c2ccc(NCC3CCOCC3)c([N+](=O)[O-])c2)cc1

nearest known ligand 0.92

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 19/20 0.92

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2791968 1.00 BCL2 (0.92) BCL2
SCHEMBL1959154 0.96 BCL2 (1.00) BCL2
SCHEMBL1955966 0.95 BCL2 (1.00) BCL2
SCHEMBL1958063 0.95 BCL2 (0.97) BCL2
SCHEMBL2790489 0.95 BCL2 (0.91) BCL2
SCHEMBL1957433 0.93 BCL2 (1.00) BCL2
SCHEMBL1956632 0.93 BCL2 (0.91) BCL2
SCHEMBL1959041 0.92 BCL2 (0.92) BCL2
SCHEMBL1957286 0.92 BCL2 (0.92) BCL2
SCHEMBL1957003 0.92 BCL2 (0.92) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507211-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2012-10-10 — — EP disclosed
Send feedback